| Literature DB >> 31450849 |
Aneta Smýkalová1,2, Barbora Sokolová2, Kryštof Foniok1, Vlastimil Matějka1,2, Petr Praus3,4.
Abstract
Exfoliated graphitic carbon nitride (g-C3N4) and two commercially available nanomaterials from titanium dioxide (P25 and CG300) were tested for the photocatalytic degradation of paracetamol (PAR), ibuprofen (IBU), and diclofenac (DIC). Prior to photocatalytic experiments, the nanomaterials were characterized by common methods, such as X-ray diffraction (XRD), UV-VIS diffuse reflectance spectroscopy (DRS), Fourier transformed infrared spectroscopy in attenuated total reflection mode (FTIR-ATR), transmission electron microscopy (TEM), physisorption of nitrogen, and dynamic vapor adsorption (DVS) of water. The sizes and specific surface area (SSA) of the TiO2 nanoparticles were 6 nm and 300 m2·g-1 for CG300 and 21 nm and 50 m2·g-1 for P25. The SSA of g-C3N4 was 140 m2·g-1. All photocatalytic experiments were performed under UV (368 nm), as well as VIS (446 nm) irradiation. TiO2 P25 was the most active photocatalyst under UV irradiation and g-C3N4 was the most active one under VIS irradiation. Photodegradation yields were evaluated by means of high performance liquid chromatography (HPLC) and reaction intermediates were identified using gas chromatography with mass detection (GC-MS). Paracetamol and ibuprofen were totally removed but the intermediates of diclofenac were observed even after 6 h of irradiation. Some intermediates, such as carbazole-1-acetic acid, 2,6-dichloraniline, and hydroxylated derivates of diclofenac were identified. This study showed that g-C3N4 is a promising photocatalyst for the degradation of pharmaceuticals in an aqueous environment, under visible light.Entities:
Keywords: TiO2; diclofenac; g-C3N4; ibuprofen; paracetamol; pharmaceuticals; photocatalytic degradation
Year: 2019 PMID: 31450849 PMCID: PMC6780102 DOI: 10.3390/nano9091194
Source DB: PubMed Journal: Nanomaterials (Basel) ISSN: 2079-4991 Impact factor: 5.076
Figure 1Diffusion reflectance spectra of the tested nanomaterials.
Figure 2X-ray diffraction (XRD) patterns of the tested nanomaterials. A—anatase, R—rutile, CN—g-C3N4.
Figure 3FTIR–ATR spectrum of the tested nanomaterials.
Figure 4TEM micrographs of TiO2 and exfoliated g-C3N4. (a) TiO2 CG300, (b) TiO2 P25, and (c,d) g-C3N4.
Basic statistics of TiO2 nanoparticles.
| Statistic | TiO2 CG300 | TiO2 P25 |
|---|---|---|
| Minimum (nm) | 2.3 | 10.6 |
| Maximum (nm) | 6.0 | 32.6 |
| Average (nm) | 4.0 | 20.5 |
| Standard deviation (nm) | 0.83 | 5.1 |
| Average confidence interval (nm) | 3.8–4.2 | 19.5–21.6 |
| Skewness | 0.121 | 0.341 |
| Kurtosis | 2.53 | 2.65 |
Figure 5Moisture adsorption and desorption isotherm plots of TiO2 (a) and g-C3N4 (b).
Figure 6Graphs of photocatalytic degradation of pharmaceuticals after 2 h of irradiation. (a) Diclofenac (DIC) under UV light; (b) paracetamol (PAR) under VIS light; (c) ibuprofen (IBU) under UV light; (d) reaction curves of PAR, DIC, and IBU in the presence of g-C3N4 under VIS irradiation.
Photodegradation efficiency of pharmaceuticals after 2 h of irradiation.
| Pharmaceutical | Photodegradation (%) | |
|---|---|---|
| Paracetamol | ||
| VIS | UV | |
| P25 | 35 | 93 |
| CG300 | 54 | 69 |
| g-C3N4 | 54 | 41 |
| Ibuprofen | ||
| P25 | 17 | 99 |
| CG300 | 13 | 94 |
| g-C3N4 | 71 | 24 |
| Diclofenac | ||
| P25 | 25 | 96 |
| CG300 | 49 | 66 |
| g-C3N4 | 77 | 73 |
Figure 7Absorption spectra of suspensions of P25 (a) and CG300 (b) and pharmaceuticals before photocatalytic reactions.
Figure 8Photocatalytic degradation of diclofenac using TiO2 P25 under UV (a) and exfoliated g-C3N4 (b) under VIS irradiation.